Sign in
Create a Profile
Stress Reduction Program to Reduce Abnormal Heart Rhythms Treated With Implantable Cardioverter Defibrillators (The RISTA Study)
Diseases and Conditions Researched
Arrhythmias, Cardiac
What is the purpose of this trial?
An implantable cardioverter defibrillator (ICD) is a small device that is implanted in the chest and uses electrical shocks to control arrhythmias, which are abnormal heart rhythms. Arrhythmias can be caused by many factors, including stress and anger. This study will evaluate the use of a stress reduction treatment (SRT) program aimed at reducing the occurrence of arrhythmias that require treatment with an ICD shock.
Participation Guidelines
Gender: Both
Click here for detailed participation information for this trial.
| Sponsors: | National Heart, Lung, and Blood Institute (NHLBI); Yale University |
|---|---|
| Dates: | February 28, 2008 |
| Last Updated: | March 30, 2012 |
| Study HIC#: | 09907011081 |
| Clinicaltrials.gov ID: | NCT00627263 |
How will my information be used?
For more information about this trial, contact:
Joanne McGloin
203-737-4234
joanne.mcgloin@yale.edu
Matthew M. Burg, PhD
203-737-1800
matthew.burg@yale.edu
How will my information be used?
When you express interest in a specific study, the information from your profile will be sent to the doctor conducting that study. If you're eligible to participate, you may be contacted by a nurse or study coordinator.
If you select a health category rather than a specific study, doctors who have active studies in that area may contact you to ask if you would like to participate.
In both cases, you will be contacted by the preferred method (email or phone) that you specified in your profile.
